e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
To treat or not to treat, and how? Sleep-disordered breathing I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical predictors of obesity hypoventilation syndrome in morbidly obese subjects with obstructive sleep apnoea
Silke Ryan (Dublin, Ireland), Silke Ryan, Audrey Russell, Geraldine Nolan, Walter McNicholas
Source:
International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Session:
To treat or not to treat, and how? Sleep-disordered breathing I
Session type:
Thematic Poster Session
Number:
2409
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Silke Ryan (Dublin, Ireland), Silke Ryan, Audrey Russell, Geraldine Nolan, Walter McNicholas. Clinical predictors of obesity hypoventilation syndrome in morbidly obese subjects with obstructive sleep apnoea. Eur Respir J 2015; 46: Suppl. 59, 2409
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Related content which might interest you:
Frequency and predictors of obesity hypoventilation syndrome in morbidly obese (BMI ≥40) patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013
Prevalence of obesity hypoventilation syndrome in OSA patients in the UAE
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Chronic hypercapnia in morbidly obese patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005
Gender difference on polysomnographic parameters of severely obese patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 331s
Year: 2007
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Obstructive sleep apnea and metabolic syndrome in thin patients; characteristics and comparation with patients with overweight and obesity
Source: Annual Congress 2012 - Sleep disorders in internal medicine
Year: 2012
Obstructive sleep apnoea and metabolic impairment in severe obesity
Source: Eur Respir J 2011; 38: 1089-1097
Year: 2011
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
Prevalence of sleep apnea syndrome in morbidly obese patients
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Biochemical basis of inflammation in children with obstructive sleep apnea syndrome (OSAS) and in children with obesity
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients
Source: Eur Respir J 2008; 31: 223-225
Year: 2008
OSA syndrome in children
Source: Eur Respir Mon 2010; 50: 104-120
Year: 2010
Evaluation of the relations between the obstructive sleep apnea syndrome and obesity by standard antropometric obesity indexes
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011
The economic consequences of snoring, obstructive sleep apnea and obesity hypoventilation syndrome
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Impact of sleep onset on hemodynamic parameters in obese patients with or without obstructive sleep apnea
Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Year: 2017
The clinical presentation of obstructive sleep apnea syndrome is different in diabetic patients
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016
Does the neutrophil-to-lymphocyte ratio have any importance between subjects with obstructive sleep apnea syndrome with obesity and without obesity?
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept